US Patent Issued to APICAL MOLECULAR BIOTECH on Nov. 11 for "Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis" (Taiwanese Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,784, issued on Nov. 11, was assigned to APICAL MOLECULAR BIOTECH Co. LTD. (Taoyuan, Taiwan).

"Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis" was invented by Tai-Huang Kuo (Tainan, Taiwan), Po-Chuen Shieh (Kaohsiung, Taiwan), Ming-Long Cheng (Taoyuan, Taiwan) and Chih-Wei Fu (Hsinchu, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A series of novel analogs of water soluble pterostilbene amino acid bearing carbonates were synthesized, which show activities in treating a non-alcoholic fatty liver disease and a nonalcoholic steatohepatitis (NASH)."

The pat...